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Abstract
Background: The infectivity of influenza A viruses can differ among the various primary cells and continuous cell
lines used for such measurements. Over many years, we observed that all things equal, the cytopathic effects
caused by influenza A subtype H1N1, H3N2, and H5N1 viruses were often detected earlier in a mink lung epithelial
cell line (Mv1 Lu) than in MDCK cells. We asked whether virus yields as measured by the 50% tissue culture
infectious dose and plaque forming titer also differed in MDCK and Mv1 Lu cells infected by the same influenza
virus subtypes.
Results: The 50% tissue culture infectious dose and plaque forming titer of many influenza A subtype H1N1, H3N2,
and H5N1 viruses was higher in Mv1 Lu than in MDCK cells.
Conclusions: The yields of influenza subtype H1N1, H3N2, and H5N1 viruses can be higher in Mv1 Lu cells than in
MDCK cells.
Background
The infectivity of influenza viruses can differ among the
various primary cells and continuous cell lines used for
such measurements [1,2]. As the term “infectivity” has
many meanings in virology, in this manuscript, infectiv-
ity is broadly defined as the ability of a virus particle to
enter a host cell and form viable progeny virions. Mea-
sures of infectivity depend not only on the inherent sus-
ceptibility of a particular type of cell for a given
influenza virus, but also on the methodology used for
infecting the cells [such as the length of time the virus
is left in contact with the cells, as the affinity/avidity of
a virus for its receptor(s) may vary according to cell
type], the quasispecies distribution within a particular
influenza virus stock, and other variables.
Accurate viable virus counts are essential for inhala-
tion exposure studies with aerosolized viruses [3], for
correlation of viable count to genome equivalence in
level of detection studies, and other relevant work with
influenza viruses. Quantitative RT-PCR methods are not
suitable, as they do not distinguish between viable and
non-viable virus particles. Indeed, infectious influenza
virus particles comprise a minor subpopulation of biolo-
gically active particles (BAP) within a viral population
[4]. The other BAP include interferon suppressing parti-
cles [4,5], defective interfering particles [4,6], and nonin-
fectious cell-killing particles [4,7].
Madin-Darby canine kidney (MDCK) epithelial cells
are widely used for the isolation of human influenza A
and B viruses and the determination of influenza A
virus titers [1,8-11]. However, we (S. Hamilton and J.
Lednicky, unpublished) and others [2,12] have observed
that all things equal, the cytopathic effects (CPE) of
many influenza A viruses are detected earlier in a mink
lung epithelial cell line (Mv1 Lu) (American Type Cul-
ture Collection [ATCC] CCL-64) than in MDCK cells.
The use of Mv1 Lu cells for the detection of influenza
v i r u s e si sn o tn o v e l ;f o re x a mple, the cells are supplied
by a commercial source (Diagnostic Hybrids, Inc.,
Athens, OH) to clinical laboratories for that purpose. In
MDCK and Mv1 Lu cells grown as a monolayer, CPE
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changes in the appearance of nuclei in infected cells,
and the formation of focal enlarged granular cells
or non-specific cell deterioration, followed by detach-
ment of the swollen cells from the growing surface.
Occasionally, influenza virus-infected Mv1 Lu cells form
spindle-shaped granular cells that do not detach from
the growing surface. A basic comparison of MDCK and
Mv1 Lu cells is given in Table 1.
The acronym Mv1 Lu stems from “Mustela vison
(American mink) lung” (now reclassified as Neovison
vison). Mink are highly related to ferrets and are suscep-
tible to influenza viruses [13]. We are performing var-
ious studies of influenza viruses in domesticated ferrets
(Mustela putorius furo), and asked whether Mv1 Lu
cells might be advantageous for the isolation and/or
enumeration of H5N1 and other influenza viruses in fer-
ret tissue specimens or secretions. An underlying
assumption of ours was that influenza viruses in speci-
mens derived from ferrets with active influenza infec-
tions would effectively attach, replicate and efficiently
produce progeny virions in Mv1 Lu cells. Moreover, we
wished to know whether virus yields might differ in
MDCK vs Mv1 Lu cells. We learned that the virus yields
of many low-passage influenza A virus strains was
higher in Mv1 Lu cells than in MDCK cells, even when
the virus had not been adapted for growth in ferrets.
Results
1. Validation of cell lines
Whereas validated low-passage MDCK cells are used in
some long-established influenza research laboratories,
such cells are no longer easy to obtain. To gain insights
applicable to current realities, MDCK and Mv1 Lu cells
obtained from various commercial or university sources
were evaluated for this work (the identity of most of the
suppliers cannot be revealed due to legally binding client
confidentiality agreements). The morphological charac-
teristics of the MDCK and Mv1 Lu cells varied among
the batches tested, and they also varied in sensitivity to
influenza viruses, cell longevity, and cell growth kinetics/
properties. Furthermore, especially since the cell lines
were established long ago, they had been propagated by
others in cell culture media supplemented with fetal
bovine serum that had not been gamma-irradiated prior
to cryopreservation/archiving. Not surprisingly, many
batches of both cell lines contained numerous multinu-
cleated large syncytia, cytoplasmic inclusion bodies, peri-
nuclear or cytoplasmic vacuoles, and other signs of viral
contamination, even in the presence of gamma-irradiated
serum (some examples are shown in Figure 1).
Various types of commercially prepared cell culture
media and serum samples were extensively evaluated
(data not shown). A batch each of MDCK and Mv1
Lu cells that lacked overt signs of viral (or other) con-
tamination, and had minimal anomalies detectable by
microscopy using phase-contrast objectives (no signs of
non-specific cell deterioration, rare vacuoles and abnor-
mal nuclei, no granulation, and less than 1 syncytium
per 6 fields at 200× magnification), and that supported
high-titer yields (≥ 4×1 0
8 PFU/ml) of Influenza virus
A/Wisconsin/67/2005 (H3N2) (used as an indicator
strain) in a series of pilot studies, were chosen for this
w o r k .D u r i n gp a s s a g e ,t h ec e lls were sub-cultured at a
minimum ratio of 1:4 to a maximum of 1:20 when they
were nearly confluent. The dimensions of trypsinized
MDCK and Mv1 Lu cells were measured using a CASY
1 resistance measuring multi-channel cell analyzer sys-
tem (Roche Innovatis AG, Reutlingen, Germany). Those
measurements indicated that the MDCK cells were
larger than the Mv1 Lu cells. For example, one day
post-seeding and cultivation under optimal conditions
(Materials and Methods), MDCK had a mean diameter
of 18.4 μm (Figure 2), whereas the mean diameter of
Mv1 Lu cells was about 12.3 μm( F i g u r e3 ) .A ss h o w n
in Figure 2 and 3, MDCK cells consistently produced
more debris than Mv1 Lu cells (compare areas of left
peaks [level of debris] in both Figures). Cell dimension
and amount of debris correlated with the source of both
serum and growth media. For example, MDCK cells
grown in optimal growth medium but sub-optimal
s e r u mh a dad i f f e r e n tp r o f i l ea t1d a yp o s t - s e e d i n g :t h e
amount of debris was comparably higher and the cell
dimension more variable (Figure 4).
2. Pandemic H1N1 2009 viruses can be propagated in
Mv1 Lu cells
We determined that various pandemic H1N1 2009 viruses
including strains A/California/04/2009 and A/California/
07/2009 can be readily propagated in Mv1 Lu cells. As
shown in Figure 5, A/California/04/2009, obtained for this
work as an MDCK-passaged virus, is able to complete its
replication cycle in Mv1 Lu cells. In Figure 5, MDCK and
Mv1 Lu cells were infected at the same high multiplicity
of infection (MOI) (approx 10); whereas some enlarged
nuclei and cytoplasmic granulation (evidence of infection
with influenza virus) are evident in the MDCK cells, most
Table 1 Characteristics of MDCK and Mv1 Lu cells
Characteristic MDCK Mv1 Lu
Morphology Epithelial Epithelial
Growth properties Adherent Adherent
Source Kidney Lung
Gender Female adult Male and female from fetuses
Doubling time
1 29 hr 20 hr
1Doubling time (this work): Time for cell to duplicate in DMEM under optimal
conditions.
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Page 2 of 9of the Mv1 Lu cells were destroyed 48 hrs post-infection.
At a MOI of 0.1 or less, nearly complete destruction of the
cells was delayed, requiring more than 48 hrs, but still fol-
lowing the previous pattern observed with high MOI:
nearly complete destruction occurred first in monolayer of
Mv1 Lu cells. Since the infected cells formed cytopathic
effects (CPE) typical of influenza viruses at low and high
MOI, the observed effects were presumed to be indepen-
dent of effects attributable to those caused by non-infec-
tious cell-killing virus particles. The virus in the Mv1 Lu
cells (Figure 5) was putatively shown to be an influenza A
virus using a commercial solid phase ELISA test
A B
C D
E F
Figure 1 Microscopic analyses of cultured MDCK and Mv1 Lu cells. A. MDCK cells, normal (200× magnification); B. MDCK cells, aberrant;
large inclusion body and vacuolation (arrow); C. MDCK cells, aberrant; Giant cell with inclusions (arrow); D. MDCK cells, aberrant; perinuclear
vacuoles (arrow); E. Mv1 Lu cells, normal (200×); F. Mv1 Lu cells, aberrant; syncytium (arrow).
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Page 3 of 9(QuickVue Influenza A kit, Quidel Corp., San Diego, CA)
kit, and confirmed as A/CA/04/2009 (H1N1) by RT-PCR
and sequencing of the viral hemagglutinin, neuraminidase,
and matrix genes (data not shown).
3. Mv1 Lu cells can be used for influenza A virus plaque
assays
To our knowledge, Mv1 Lu cells have not been used for
influenza virus plaque assays by other laboratories
(supporting literature was not found). We now disclose
that we have used Mv1 Lu cells for plaque assays of a
variety of influenza A viruses. Examples are shown for
A/Mongolia/244/2005 (H5N1) [Figure 6] and for A/
California/04/2009 (H1N1) [Figure 7].
4. Titration of influenza H5N1 viruses
Following the general outline depicted in Figure 8, the
plaque and 50% tissue culture infectious dose (TCID50)
Figure 2 MDCK cell profile under optimal conditions and serum, one day post-seed. Ordinate, cell count (CNT); abscissa, diameter of cell
or other particles (μm).
Figure 3 Mv1 Lu cell profile under optimal conditions and serum, one day post-seed. Ordinate, cell count (CNT); abscissa, diameter of cell
or other particles (μm).
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Page 4 of 9titers of 4 different H5N1 influenza viruses grown in
embryonated chicken eggs were determined in MDCK
and Mv1 Lu cells. The titers of the H5N1 viruses were
higher in Mv1 Lu than MDCK cells (Table 2). For these
H5N1 viruses, CPE were usually evident up to 6 hr ear-
lier in Mv1 Lu cells than in MDCK cells (data not
shown). Similar results were obtained with viruses first
propagated in MDCK or Mv1 Lu cells instead of eggs as
shown in Figure 8: higher titers resulted when Mv1 Lu
cells were used for plaque or TCID50 determinations
(data not shown).
5. Titration of seasonal and pandemic H1N1 2009
influenza viruses
Again following the procedure depicted in Figure 8, mar-
ginally to significantly higher viral titers were also calcu-
lated in Mv1 Lu cells than MDCK cells with various
egg-grown seasonal and pandemic H1N1 2009 influenza
viruses (Table 3). As for H5N1 viruses, similar results
were obtained with viruses first propagated in MDCK
and Mv1 Lu cells instead of eggs as shown in Figure 8:
higher titers resulted when Mv1 Lu cells were used for
plaque or TCID50 determinations (data not shown).
Figure 4 MDCK cell profile under optimal conditions but with lower-quality serum, one day post-seed. Ordinate, cell count (CNT);
abscissa, diameter of cell or other particles (μm).
A B
Figure 5 Appearance of MDCK and Mv1 Lu cells 48 hr after infection of the cells at a high MOI with a pandemic H1N1 2009 virus.
Enlarged nuclei and cellular granulation but no cellular detachment are evident in the MDCK cells (panel A), whereas most of the Mv1 Lu cells
have detached or are showing advanced CPE (panel B).
Hamilton et al. Virology Journal 2011, 8:66
http://www.virologyj.com/content/8/1/66
Page 5 of 9Discussion
As for MDCK cells, Mv1 Lu cells can be used for both
influenza A virus TCID50 and plaque assays. And in
establishing parameters for the enumeration of various
influenza A strains, we observed that higher virus titers
were attained for many in Mv1 Lu cells compared to
the titer obtained in the more commonly used MDCK
cell line. Taken together, it may be advantageous to use
Mv1 Lu cells for certain applications, such as for obtain-
ing estimates of a delivered dose of aerosolized influenza
virus in inhalation exposure studies [3], and for the
detection of relatively small amounts of infectious influ-
enza virus particles in tissue or secretion specimens.
Though not specifically mentioned in the body of this
manuscript, we noted that Mv1 Lu cells must be
handled as described (Materials and Methods). When
Mv1 Lu cells are maintained confluent for more
than 1 week without splitting them for virus titration,
variability in the CPE caused by influenza viruses occurs,
Mv1 Lu  MDCK
Figure 7 Comparison of plaques formed by A/California/04/2009 (H1N1) in Mv1 Lu and MDCK cells.
-1 -2 -3
Non-infected -4 -5
Figure 6 Plaque assay of A/Mongolia/244/2005 (H5N1) in Mv1
Lu cells.
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Page 6 of 9as reported by Schultz-Cherry et al [2]. In the impro-
perly maintained Mv1 Lu cells, the appearance of CPE
is typically delayed compared to MDCK cells, and these
Mv1 Lu cells cannot be used for plaque assays.
Materials and methods
1. Cells
MDCK and Mv1 Lu from Diagnostic Hybrids, Inc. were
selected for this work. The MDCK cells were obtained at
passage 68 and used through passage 78, Mv1 Lu cells at
passage 71 and used through passage 88. Both cell lines
were cultured as monolayers at 37ºC and 5% CO2. Both
cell lines were routinely propagated in either Dulbecco’s
Modifed Eagle’s Medium (DMEM) (Mediatech, Inc.,
Manassas, VA) or Earle’s Minimal Essential Medium
(EMEM) (Invitrogen Corp., Carlsbad, CA). Both medium
formulations were supplemented with 2 mM L-Alanyl-L-
Glutamine (GlutaMAX™, Invitrogen Corp.), antibiotics
[PSN; 50μg/ml penicillin, 50 μg/ml streptomycin,
100 μg/ml neomycin (Invitrogen Corp.)], and 10% (v/v)
heat-inactivated gamma-irradiated fetal bovine serum
(HyClone, Logan, Utah). Sodium pyruvate (Invitrogen
Corp.) and non-essential amino acids (Hyclone) were
added to EMEM (each at a manufacturer’s recommended
final concentration of 1×). Prior to virology tests, the fol-
lowing precautionary steps were taken to reduce possible
mycoplasma and other contamination: the pre-banked
cells were propagated in plasmocin (Invivogen, San
Diego, CA) containing growth media for two weeks,
followed by two weeks in the absence of antibiotics to
determine whether fast-growing microbial contaminants
were present or abnormal morphological changes would
occur. The cells were confirmed negative by PCR for the
presence of mycoplasma DNA using a Takara PCR
Mycoplasma Detection kit (Takara Bio, USA, Thermo
Fisher), and by mycoplasma tests (culture and DNA
staining) performed by a commercial testing laboratory
(Bionique Testing Laboratories, Saranac Lake, NY). The
cell lines were observed daily to monitor confluency and
checked for normal morphology. They were split when
they reached ~90% confluency. Cell counts were per-
formed on harvested cultures using either trypan blue
dye-exclusion hemacytometer methodology or by auto-
mated cell size analysis (CASY 1 counter).
Actively growing MDCK and Mv1 Lu cells were
planted at 1-3 × 10
3 viable cells/well in 96 well microti-
ter plates a minimum of three days prior to assay. Like-
wise, 6-well microtiter plates were planted at least three
days prior to performing a plaque assay at a seeding
density of 3-6 × 10
5 viable cell/well. Cell banks were
prepared by freezing actively growing cells in standard
growth medium containing 5% DMSO. After rapid
thawing of frozen vials of cells, each vial was centri-
fuged, the freeze medium was discarded, and the cell
pellet was resuspended in growth medium for planting
culture vessels.
2. Influenza viruses
Influenza virus H5N1 strains A/Vietnam/1203/2004 and
A/Mongolia/244/2005 were from archives of the South-
east Poultry Research Laboratory, and A/Iraq/207-
NAMRU3/2006 was from the National Biodefense Ana-
lysis and Countermeasures Center [NBACC], which
obtained the virus from Naval Medical Research Unit
No. 3 [NAMRU-3], Cairo, Egypt (37) (Table 1). The
H5N1 viruses were received as low-passage stocks, and
their identity verified using viral genomic sequencing.
Other influenza viruses were obtained from the Centers
for Disease Control and Prevention or from the ATCC.
3. Virus propagation
Low-passage stocks of the H5N1 viruses were propa-
gated in the allantoic cavities of 10-day-old embryonated
Table 2 Titers of egg-grown H5N1 viruses in MDCK and Mv1 LU cells
H5N1 Virus MDCK cells Mv1 Lu cells
Log10TCID50/ml Log10PFU/ml Log10TCID50/ml Log10PFU/ml
A/Vietnam/1203/2004 7±0.2 6.8±0.2 8±0.2 7.9±0.2
A/Mongolia/244/2005 6.4±0.1 6±0.2 8±0.2 7.8±0.2
A/Iraq/207-NAMRU3/2006 8.8±0.2 8.3 10±0.2 9.9
aTCID50 data from three separate experiments, plaque assay data from 1 (A/Iraq/207-NAMRU3/2006) or 3 (A/Vietnam/1203/2004 and A/Mongolia/244/2005)
experiments.
Virus 
Egg
Incubate ч Ϯϰ Ś at ϯϳ °C
Refrigerate egg
Collect allantoic fluid
MDCKM v 1  L u
Figure 8 Outline of process used for comparing titers of
egg-grown virus in MDCK and Mv1 Lu cells.
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Page 7 of 9chicken eggs (ECE) for 24 h at 37°C; the allantoic fluid
was harvested, centrifuged for clarification, and stored at
-80°C for up to one year or in the vapor phase of liquid
nitrogen for longer storage [3,11,14,15]. All work with
H5N1 viruses was conducted in a Biosafety Level 3
enhanced laboratory. Subtype H1 and H3 influenza
viruses were propagated in ECE or in MDCK cells
(using the same substrate they were propagated in at
the ATCC or CDC).
4. Calculation of TCID50 values
TCID50 values were determined by infecting MDCK and
Mv1 Lu cells in 96-well microtiter plates with serial
dilutions of virus and calculation of the TCID50 four
days later by the method of Reed and Muench [16].
Cells for TCID50 determinations were in serum-free
complete EMEM containing L-1-tosylamide-2-pheny-
lethyl chloromethyl ketone (TPCK)-treated trypsin, and
re-fed with the same medium. As the specific activity of
the TPCK-trypsin was relatively high, the final concen-
trations of TPCK-trypsin were 1.0 μg/ml for MDCK
cells and 0.1 μg/ml for Mv1 Lu cells.
5. Plaque assays
For plaque assays, newly confluent MDCK or Mv1 Lu
cells in six-well tissue cultu r ep l a t e sw e r ei n o c u l a t e d
with 0.2 ml of virus serially diluted in serum-free com-
plete EMEM containing TPCK-treated trypsin. Virus
was adsorbed to cells for 1 hr at 37ºC (H5N1) or 35ºC
(seasonal influenza viruses) with rocking every 15 min
(2009 pandemic influenza H1N1 were adsorbed for 2 h
at 35ºC). After virus adsorption, the cells were washed
with serum-free EMEM and the wells overlaid with
3 ml/well of primary overlay consisting of 1.6% w/v
agarose (Invitrogen Corp.) mixed 1:1 with serum-free
2X EMEM (Lonza, Walkersville, MD) containing anti-
biotics and TPCK-trypsin. With the exception of H1N1
pandemic influenza 2009 viruses, plates were inverted
and incubated for 3 days at temperatures appropriate
for the viruses, then overlaid with 2 ml of secondary
overlay of 1.6% w/v agarose mixed 1:1 with 2X EMEM
containing 0.14 mg/ml neutral red (catalog number
N2889, Sigma-Aldrich, St. Louis, MO), the plates
inverted, and incubated for two additional days to visua-
lize plaques. The pandemic 2009 H1N1 viruses required
longer incubation times: 3 days after the primary overlay
(performed as described above), the cells were overlaid
2 ml/well of 1.6% w/v agarose (Invitrogen Corp.) mixed
1:1 with serum-free 2X EMEM (Lonza) containing anti-
biotics and TPCK-trypsin, inverted, and incubated for
another 2 days. They were subsequently overlaid with
2 ml of secondary overlay with neutral red as described
above, and the plates incubated for 2 additional days to
visualize plaques.
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